Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…e primary outcome was the association between time to first AT (Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab or Tofacitinib…
…Introduction Infliximab (IFX) improves outcomes in Inflammatory Bowel Disease; however …
…uired minor adjustment. Templates of moderate duration included ustekinumab, vedolizumab, and adalimumab counselling, with completion times…
… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…
…elective immunosuppressive therapy (SIT) such as infliximab and vedolizumab. The aim of our study was to assess for factors predicting need…
…iatric population of people living with IBD treated with either infliximab or vedolizumab who were recruited to the UK CLARITY IBD to stud…
…, nocturnal non-invasive ventilation and immunosuppression with infliximab. Subsequent escalation of management included endobronchial ste…
…ical response. Genetic testing confirmed DADA2, following which infliximab therapy was initiated, resulting in clinical stabilisation and …
…scarnet, cidofovir, or immunotherapies. New treatments, such as maribavir, have shown promise for refractory cases. This report discusses…
…e corticosteroids and physiotherapy were initiated, followed by infliximab as a steroid-sparing agent. Follow-up demonstrated radiological…
…mber 2024, three Trusts received the highest number of requests.Infliximab for IBD was the most frequently requested drug; haematology was…
…le therapeutic options, anti-TNFα monoclonal antibodies such as infliximab (IFX) and adalimumab (ADA) are widely used in moderate-to-sever…